Human antibody for Zika virus promising for treatment, prevention

March 16, 2017
This color-coded image depicts the surface view of the Zika virus bound to fragments of a human antibody, shown as red knobs. Researchers have determined the structure of the antibody bound to the virus, findings that could aid in development of antiviral medications. Credit: Purdue University image/S. Saif Hasan

Researchers have determined the structure of a human antibody bound to the Zika virus, revealing details about how the antibody interferes with the infection mechanism—findings that could aid in development of antiviral medications.

The new findings also suggest the antibody might be especially effective because a lower concentration than expected is needed to inhibit a key mechanism of infection, making it more potent than previous studied. The research was performed by a team from Purdue University, Vanderbilt University Medical Center and the Washington University School of Medicine.

The was isolated by the Vanderbilt and Washington University researchers, who reported their findings earlier this year. Those findings showed that the antibody, which was isolated from a person previously infected with Zika , neutralizes Zika strains that belong to African, Asian and American lineages and is able to reduce fetal infection and death in mice.

"However, until now what remained unknown was the mechanism of neutralization of Zika infection by the antibody and the structural basis for neutralization," said Michael Rossmann, Purdue's Hanley Distinguished Professor of Biological Sciences.

The findings are being reported today (March 16) in the journal Nature Communications.

The research team was led by Rossmann and Richard Kuhn, both professors in Purdue's Department of Biological Sciences, and senior postdoctoral scientist S. Saif Hasan. Research to isolate the antibody was led by James E. Crowe Jr., a professor of pediatrics, pathology, microbiology and immunology at Vanderbilt, and Michael S. Diamond, the Herbert S. Gasser Professor at Washington University.

Zika belongs to a family of viruses called flaviviruses, which includes dengue, West Nile, yellow fever, Japanese encephalitis and tick-borne encephalitic viruses.

In the new findings, researchers determined the combined three-dimensional structure of the Zika virus while attached to a key binding site on the antibody known as the antigen binding fragment, or a Fab molecule.

"It has potential to be a therapeutic neutralizing human antibody" said Kuhn, director of the Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D).

The genome of the Zika virus is housed inside a protective shell that includes 60 repeating units, each containing three envelope proteins, or E proteins. As the virus attaches to a host cell's outer membrane a difference in pH, or acidity, in the membrane causes these "trimers" to expose "fusion peptides," leading to the transfer of the viral RNA genome, a step critical to infection. The new findings show the antibody's binding to Zika inhibits this pH-triggering mechanism, neutralizing the virus by "cross-linking" the E proteins, tying them up and preventing their reorganization into "fusogenic" trimers.

"This hypothesis is supported by pre- and post-neutralization assays of Zika infection, showing the antibody is able to significantly inhibit infection," Rossmann said. "This approach should provide broad-range protection against virtually all strains of Zika."

Moreover, considering that the surface of Zika is made of 60 copies of three E proteins, it would be expected that 180 copies of the antibody's Fab molecules would be needed for neutralization.

"However, one antibody binds for six E proteins, so only 30 are needed," Hasan said. "Therefore, you don't need a high concentration of antibodies to achieve neutralization."

The findings primarily will aid in the development of antiviral drugs but also will help researchers identify important sites on the virus for human antibodies to hook onto, which could be useful in developing vaccines down the road, Kuhn said.

The researchers determined the structure at a resolution of 6.2 Ångstroms using a technique called cryo-electron microscopy.

The Zika virus has been associated with a birth defect called microcephaly that causes brain damage and an abnormally small head in babies born to mothers infected during pregnancy. The virus also has been associated with the autoimmune disease Guillain-Barré syndrome, which can lead to temporary paralysis.

"Given the severity of the symptoms caused by Zika infection in humans, it is crucial to understand the immune response elicited by the infection to develop neutralizing anti-Zika therapies," Rossmann said. "In contrast to other flaviviruses that are spread mainly by insects, recent evidence suggests that Zika can be transmitted sexually and from mother to child in addition to transmission by mosquitoes."

The first major outbreak of the Zika virus was recorded in 2007 in Micronesia and then in 2013-14 in Oceania. The latest outbreak, which started in Brazil in 2014-15, has spread to other countries in South America, North America and the Caribbean. Four cases of fetal deformities were reported in December 2016 in New York City.

Explore further: Immune molecule protects against Zika virus infection in animal models

More information: S. Saif Hasan et al, A human antibody against Zika virus crosslinks the E protein to prevent infection, Nature Communications (2017). DOI: 10.1038/ncomms14722

Related Stories

Immune molecule protects against Zika virus infection in animal models

March 14, 2017
A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found. Administering the molecule, called 25-hydroxycholesterol or 25HC, ...

Early study finds antibody that 'neutralizes' Zika virus

November 7, 2016
Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis, Missouri, have isolated a human monoclonal antibody that in a mouse model "markedly reduced" infection by the ...

First steps to neutralizing Zika: How highly potent antibody neutralizes Zika infection discovered

November 24, 2016
As Zika spreads throughout the world, the call for rapid development of therapeutics to treat Zika rings loud and clear. Taking a step further in identifying a possible therapeutic candidate, a team of researchers at Duke-NUS ...

Pre-existing immunity to dengue virus shapes Zika-specific T cell response

March 13, 2017
Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and ...

Lab vaccine shields mice against Zika virus

December 14, 2016
Antibodies drawn from a patient infected with Zika could form the basis of a vaccine against the notorious virus, a new animal study suggests.

Recommended for you

Researcher identifies a new way to treat HIV

August 24, 2017
Medical treatment that targets human proteins rather than ever-mutating viruses may one day help HIV-positive people whose bodies have built a resistance to "cocktails" currently used to keep them healthy, according to a ...

New insights into the world of trypanosomes

August 23, 2017
Single specimens of the vermicular pathogens causing sleeping sickness swim inside the gut of the tsetse fly between blood cells which the fly has ingested from an infected mammal. This is where they start their week-long ...

Survey of DNA fragments circulating in the blood suggests vast microbial diversity

August 23, 2017
A new survey of DNA fragments circulating in human blood suggests our bodies contain vastly more diverse microbes than anyone previously understood. What's more, the overwhelming majority of those microbes have never been ...

Study a breakthrough in understanding chronic pain in children

August 23, 2017
A University of Calgary psychologist who studies pediatric pain has made a breakthrough in understanding the cause of chronic pain in adolescents—by focusing on those recovering from major surgeries.

Scientists develop infection model for tickborne flaviviruses

August 22, 2017
National Institutes of Health (NIH) scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a ...

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.